Circulating N-terminal pro-B-type natriuretic peptide in fetal anemia before and after treatment
暂无分享,去创建一个
[1] B. Stoffel‐Wagner,et al. N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations , 2012, Clinical Research in Cardiology.
[2] N. Uldbjerg,et al. Parvovirus B19 infection in human pregnancy , 2011, BJOG : an international journal of obstetrics and gynaecology.
[3] T. Tongsong,et al. Venous Doppler studies in low-output and high-output hydrops fetalis. , 2010, American journal of obstetrics and gynecology.
[4] B. Stoffel‐Wagner,et al. Reference values for N-terminal pro-B-type natriuretic peptide in fetal circulation between 20 and 34 weeks of gestation. , 2010, Clinical biochemistry.
[5] K. Thornburg,et al. Cardiomyocyte enlargement, proliferation and maturation during chronic fetal anaemia in sheep , 2010, Experimental physiology.
[6] J. Deprest,et al. Methods for prenatal assessment of fetal cardiac function , 2009, Prenatal diagnosis.
[7] W. Arzt,et al. Amino Terminal pro B-Type Natriuretic Peptide Levels Are Elevated in the Cord Blood of Neonates With Congenital Heart Defect , 2009, Pediatric Research.
[8] D. Oepkes,et al. Total Blood Volume Is Maintained in Nonhydropic Fetuses with Severe Hemolytic Anemia , 2009, Fetal Diagnosis and Therapy.
[9] Y. O. Xu-Cai,et al. Molecular forms of natriuretic peptides in heart failure and their implications , 2009, Heart.
[10] S. Gudmundsson,et al. Biochemical tissue-specific injury markers of the heart and brain in postpartum cord blood. , 2009, American journal of obstetrics and gynecology.
[11] Michael Böhm,et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.
[12] Elisenda Eixarch,et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. , 2008, American journal of obstetrics and gynecology.
[13] A. Jaffe,et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. , 2008, Clinical chemistry.
[14] P. Collinson,et al. Amino-terminal pro-B-type natriuretic peptide: analytic considerations. , 2008, The American journal of cardiology.
[15] K. Moise. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. , 2008, American journal of obstetrics and gynecology.
[16] Faquan Liang,et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. , 2007, Journal of the American College of Cardiology.
[17] O. Vuolteenaho,et al. Cardiovascular hemodynamics and umbilical artery N‐terminal peptide of proB‐type natriuretic peptide in human fetuses with growth restriction , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[18] T. Scholz,et al. Myocardial vascular and metabolic adaptations in chronically anemic fetal sheep. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[19] M David Tilson,et al. The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease. , 2005, Circulation.
[20] M. McGrath,et al. Determinants of natriuretic peptide gene expression , 2005, Peptides.
[21] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[22] G. Giraud,et al. The effects of anaemia as a programming agent in the fetal heart , 2005, The Journal of physiology.
[23] O. Vuolteenaho,et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. , 2004, Clinical chemistry.
[24] K. Thornburg,et al. Fetal anemia leads to augmented contractile response to hypoxic stress in adulthood. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[25] V. Cameron,et al. Minireview: natriuretic peptides during development of the fetal heart and circulation. , 2003, Endocrinology.
[26] A. Baschat,et al. Coronary artery blood flow velocities in various fetal conditions , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[27] A. Baschat,et al. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[28] S. Blackwell,et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. , 2000, The New England journal of medicine.
[29] Giancarlo Mari,et al. NONINVASIVE DIAGNOSIS BY DOPPLER ULTRASONOGRAPHY OF FETAL ANEMIA DUE TO MATERNAL RED-CELL ALLOIMMUNIZATION , 2000 .
[30] K. Nicolaides,et al. Fetal Venous, Arterial and Intracardiac Blood Flows in Red Blood Cell Isoimmunization , 1995, Obstetrics and gynecology.
[31] Y. O. Xu-Cai,et al. failure and their implications Molecular forms of natriuretic peptides in heart , 2010 .
[32] L. R. Potter,et al. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. , 2009, Handbook of experimental pharmacology.
[33] D. Paladini,et al. Cardiac troponin T and amino-terminal pro-natriuretic peptide concentrations in fetuses in the second trimester and in healthy neonates , 2006, Clinical chemistry and laboratory medicine.
[34] M. Emdin,et al. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. , 2004, Clinical chemistry.